Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Sells $101,332.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 188 shares of the stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $101,332.00. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,720,023. The trade was a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Jamie Samath also recently made the following trade(s):

• On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48.
• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00.
• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $541.71 on Wednesday. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $552.00. The firm’s 50 day simple moving average is $512.25 and its two-hundred day simple moving average is $471.53. The stock has a market capitalization of $192.95 billion, a P/E ratio of 87.09, a PEG ratio of 5.34 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ISRG. Garde Capital Inc. bought a new position in shares of Intuitive Surgical in the third quarter worth approximately $103,000. Peapack Gladstone Financial Corp grew its holdings in shares of Intuitive Surgical by 1.3% in the third quarter. Peapack Gladstone Financial Corp now owns 13,085 shares of the medical equipment provider’s stock worth $6,427,000 after purchasing an additional 167 shares during the last quarter. Synovus Financial Corp grew its holdings in shares of Intuitive Surgical by 1.1% in the third quarter. Synovus Financial Corp now owns 2,572 shares of the medical equipment provider’s stock worth $1,264,000 after purchasing an additional 28 shares during the last quarter. Destination Wealth Management grew its holdings in shares of Intuitive Surgical by 4.1% in the third quarter. Destination Wealth Management now owns 770 shares of the medical equipment provider’s stock worth $378,000 after purchasing an additional 30 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB grew its holdings in shares of Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have commented on ISRG. Leerink Partners upped their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Truist Financial increased their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $536.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.